| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/31/2002 | EP1226119A2 Tyrosine kinase inhibitors |
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP1226110A1 Bicyclic amino acids as pharmaceutical agents |
| 07/31/2002 | EP1225922A1 Selective toxin expression in angiogenic endothelial cells |
| 07/31/2002 | EP1225915A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/31/2002 | EP1225905A1 The use of a positively charged carbohydrate polymer for the prevention of infection |
| 07/31/2002 | EP1225900A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/31/2002 | EP1225896A1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors |
| 07/31/2002 | EP1225894A1 Fab i inhibitors |
| 07/31/2002 | EP1225888A2 Sustained-release formulations for treating cns-mediated disorders |
| 07/31/2002 | EP0975312B1 Compositions containing an antifungal and a phospholipid |
| 07/31/2002 | EP0799047B1 Viscous liquid conditioning topical germicides |
| 07/31/2002 | EP0760650B1 Antimicrobial oil-in-water emulsions |
| 07/31/2002 | CN1361792A Cyclic peptide derivatives as inhibitors of integrin alpha/beta |
| 07/31/2002 | CN1361790A Amine-modified pseudomycin compounds |
| 07/31/2002 | CN1361780A Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 07/31/2002 | CN1361779A New compounds |
| 07/31/2002 | CN1361773A Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/31/2002 | CN1361767A 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 07/31/2002 | CN1361763A Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha |
| 07/31/2002 | CN1361760A Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
| 07/31/2002 | CN1361694A Glycyrrhizin preparations for transmucosal absorption |
| 07/31/2002 | CN1361690A Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 07/31/2002 | CN1361688A Nitroimidazole external preparations for dermatosis |
| 07/31/2002 | CN1361680A Use of at least one extract of aplant of the genus lannea in a cosmetic or dermopharmaceutical composition |
| 07/31/2002 | CN1361666A Cactus fruit health products |
| 07/31/2002 | CN1360940A Nanometer psoriasis-treating medicine and its prepn |
| 07/31/2002 | CN1360936A Nanometer Yunnan Baiyao medicine and its prepn |
| 07/31/2002 | CN1360917A Nanoemter alopecia treating medicine and its prepn |
| 07/31/2002 | CN1360905A Cancer treating astringent medicine decoction |
| 07/31/2002 | CN1360904A Mongolian medicine ointment for treating psoriasis |
| 07/31/2002 | CN1360899A Dermatitis-treating bezoar medicine and its prepn |
| 07/31/2002 | CN1360895A Medical composition for treating dermatosis |
| 07/31/2002 | CN1360888A Mixed antigen medicine for treating benign and malignant skin lesion |
| 07/31/2002 | CN1088459C 1,4-disubstituted piperazines |
| 07/31/2002 | CN1088371C Hair-blackening and hair-growing capsule |
| 07/31/2002 | CN1088367C Colour-restoring ointment for treating burn or scald |
| 07/31/2002 | CN1088360C High efficient anti-inflammatory and antipruritic ointment and its producing method |
| 07/31/2002 | CN1088355C Bath lotion |
| 07/31/2002 | CN1088354C Bromhidrosis-removing powder |
| 07/31/2002 | CA2369462A1 Nicotinamide acids, amides, and their mimetics active as inhibitors of pde4 isozymes |
| 07/30/2002 | US6426413 Inhibitors of caspases |
| 07/30/2002 | US6426402 Respiratory system disorders; rheumatic diseases |
| 07/30/2002 | US6426199 Isolated, purified nucleic acid detecting or isolating mutant forms of the dna molecules. |
| 07/30/2002 | US6426092 Powder compositions comprising a skin irritation reducing agent |
| 07/30/2002 | US6426071 Administering protein c |
| 07/30/2002 | US6426067 Cardiovascular disorders; antitumor agents |
| 07/30/2002 | US6426066 Use of physiologically balanced, ionized, acidic solution in wound healing |
| 07/30/2002 | CA2236021C Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities: process of making metho ds of using and compositions thereof |
| 07/30/2002 | CA2160543C Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 07/30/2002 | CA2104461C Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 07/25/2002 | WO2002057778A1 Screening assay for cotranslational translocation interfering compounds |
| 07/25/2002 | WO2002057454A2 Receptors and membrane-associated proteins |
| 07/25/2002 | WO2002057453A2 Polypetides and nucleic acids encoding same |
| 07/25/2002 | WO2002057452A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | WO2002057298A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | WO2002057265A1 Compounds substituted with bicyclic amino groups |
| 07/25/2002 | WO2002057260A1 Compounds for use in the treatment of skin conditions |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | WO2002057237A1 Hetero-tricyclic compounds having substituted amino groups |
| 07/25/2002 | WO2002057230A1 Il-8 receptor antagonists |
| 07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | WO2002056901A2 Cosmetic or pharmaceutical preparations of the treatment of epithelial outer tissue |
| 07/25/2002 | WO2002056897A2 Pharmaceutical for stimulating the regeneration of tissues |
| 07/25/2002 | WO2002056896A2 Treatment solution in addition to dressing material for caring for wounds |
| 07/25/2002 | WO2002056894A1 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 07/25/2002 | WO2002056874A2 Lipid-based nitric oxide donors |
| 07/25/2002 | WO2002056873A2 2-substituted dibenzo[a,e]1,2,3-triazolo[4,5-c][7]annulen-8-ones as growth hormone secretagogues |
| 07/25/2002 | WO2002056856A1 Cosmetic product |
| 07/25/2002 | WO2002056852A1 Cosmetics |
| 07/25/2002 | WO2002056790A2 Delivery of therapeutic capable agents |
| 07/25/2002 | WO2002043652A3 Anti-proliferative drugs |
| 07/25/2002 | WO2002039988A3 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 07/25/2002 | WO2002039960A3 Cosmetic method of treating skin |
| 07/25/2002 | WO2002032901A3 Bridged piperazine derivatives |
| 07/25/2002 | WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002015886A3 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 07/25/2002 | WO2002015851A3 Storage stable tretinoin and 4-hydroxy anisole containing topical composition |
| 07/25/2002 | WO2002014320A3 Novel substituted diaryl azepine derivatives as integrin ligands |
| 07/25/2002 | WO2002000183A3 Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001039795A9 Attenuation of fibroblast proliferation |
| 07/25/2002 | WO2001004157A9 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | US20020099216 Compounds useful in therapy |
| 07/25/2002 | US20020099214 For prophylaxis and therapy of pruritus |
| 07/25/2002 | US20020099209 Dihydrostilbene alkanoic acid derivatives |
| 07/25/2002 | US20020099207 Has activity as an antagonist to neurokinin 1 receptors; for therapy of benign prostatic hyperplasia (BPH) |
| 07/25/2002 | US20020099169 Modulation of preferential transcription factor; obtain sample containing transcription factor, incubate with modulator, monitor transcriptional activity |
| 07/25/2002 | US20020099095 For treatment and prophylactic treatment of ageing of the skin, for pretreatment or after-treatment of hair or scalp or of the hair root region, in particular before or after hair treatment, for example during colouring |
| 07/25/2002 | US20020099094 Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris |
| 07/25/2002 | US20020099079 Treating psoriasis, ulcers, gastroesophageal reflux and conditions caused by gastric hypersecretion including Zollinger-Ellison Syndrome, by administering hydroxylansoprazole or salt |
| 07/25/2002 | US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
| 07/25/2002 | US20020099068 I kappa B kinase inhibitors for treating various disorders including arthritis |
| 07/25/2002 | US20020099054 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 07/25/2002 | US20020099031 Hemostatic agent |
| 07/25/2002 | US20020098527 Gene recombinant antibody and antibody fragment thereof |
| 07/25/2002 | US20020098218 Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions |